To evaluate the management of overweight and obesity in coronary artery disease patients in Europe.
Introduction
Prevention of modifiable risk factors in coronary heart disease remains a major issue worldwide [1] [2] [3] [4] . Primary prevention, because of cultural and secular behaviour, is less immediately achievable than secondary prevention. Moreover, risk factor modification after a non-fatal coronary event may be strongly motivated. Secondary prevention is of the highest priority according to the joint European Society recommendations on prevention of coronary heart disease in clinical practice [5] . Several modifiable risk factors are outlined in these recommendations: dyslipidaemia, hypertension, tobacco smoking, diabetes control, overweight and obesity. Among these, overweight and obesity are the easiest to detect, but necessitate a continuous and sustained effort. Obesity is associated with increases in all causes of death and particularly of cardiovascular mortality. Moreover, obesity is related to other risk factors, such as hypertension, dyslipidaemia and non-insulin dependent diabetes, whose deleterious effects act synergistically [6] . All these considerations are now fully accepted by physicians. Our aim was to analyse the level of detection and management of overweight and obesity in European populations of patients with established coronary heart disease. Following the first Joint European society recommendations in 1994 [5] , recently updated in 1998 [7] , a large European epidemiological study was launched under the auspices of the European Society of Cardiology, the EUROASPIRE study (EUROpean Action on Secondary Prevention through Intervention to Reduce Events). In nine countries, patients with an established coronary heart disease were enrolled from hospital admission lists, were interviewed and examined at least 6 months after their initial admission. Levels and management of cardiovascular risk factors were collected and measured. In the present study, we explored the way overweight and obesity were taken into account in medical records, we compared these data with patient anthropometric details, and enquired after the management of these risk factors since admission.
Population and methods

Study population
The design and protocol of the EUROASPIRE study are described in detail elsewhere [8] . Nine European countries were involved in the study: Czech Republic (CZE/PP), Finland (FIN/KUO), France (FRA/LLR), Germany (GER/MUN), Hungary (HUN/BUD), Italy (ITA/UTV), the Netherlands (NET/ROT), Slovenia (SLO/LJU) and Spain (SPA/BAR). In a defined geographical area in each country, at least 525 consecutive male or female patients (<70 years), including those who died, were identified retrospectively from diagnostic registers, hospital discharge lists or other sources over a period of not less than 6 months and up to 48 months prior to the start of the survey, with the following diagnosis: (i) first elective or emergency coronary bypass grafting (CABG), (ii) first elective or emergency percutaneous transluminal coronary angioplasty (PTCA) without previous CABG, (iii) first or recurrent acute myocardial infarction without previous CABG or PTCA, (iv) acute myocardial ischaemia without previous CABG or PTCA or acute myocardial infarction. In each country, the object was to obtain information on about 400 living patients attending for interview (100 per category). Thus, to allow for deaths and non-response to invitations for interview, at least 525 consecutive patients were identified.
Data collection
Data collection was conducted in two stages: first, a retrospective review of hospital medical files; second, an interview and examination of patients performed at least 6 months after their admission. Trained research personnel abstracted data from patient's medical records and interviewed and examined the patients at hospital or at home using standardized methods and instruments. Patients were invited to this interview by mail and phone and their general practitioner was informed.
Personal and demographic details, personal and family history of coronary heart disease, risk factor recordings and medication were obtained from medical records. Recorded height and weight were collected. The written opinion of the physician on the existence of obesity and the actions proposed to combat this risk factor were extracted from medical files.
At least 6 months after hospitalization, data on personal and family history were collected, height and weight were measured with scales and measuring sticks. Each subject was asked if he/she had been offered any personal advice about weight reduction; if yes, how and by whom, and if he/she had attempted to lose weight.
Statistical analyses
Body mass index was calculated as the patients' weight (in kilograms) divided by the squared height (in metres). Overweight and obesity were defined according to WHO recommendations based on body mass index limits: overweight was defined as body mass index d25 kg . m 2 , and obesity as body mass index d30 kg . m 2 [9] . Mean and standard deviation of height value differences at admission and at interview were computed. Differences from zero were statistically evaluated according to 95% confidence intervals.
Results
A total of 4863 patient records were reviewed. Twenty five percent were women. The age distribution was as follows: c50 years 23·1%, 51-60 years 33·8% and 61-70 years 43·1%. Interviews were obtained for 73·4% (3569/ 4863) of the patients. Among those who did not participate in the interview, 5·8% had died, 7·5% were lost to follow-up, 7·3% refused to participate, 3·8% did not respond and 2·2% gave other reasons for not participating. The proportion of obese subjects interviewed and those who were not, as calculated from record data, were identical, respectively, 18% and 19%.
Height was recorded in 86% and weight in 88% of hospital medical files. A systematic significant (P<0·001) positive difference between height values measured at interview and height values reported in admission records was observed for all countries (Table 1) . This difference was +1·1 cm (95% CI=[1·1-1·2]) for men and +2·6 cm (95% CI=[2·3-2·8]) for women.
The prevalence of overweight (Table 2a) and obesity (Table 2b) was computed according to different body mass index calculations obtained by combining height and weight recorded in medical notes, and measurements collected at interview. The lowest prevalences of overweight and obesity were observed at admission and the highest ones at interview. When the height at interview was used to calculate body mass index at admission, intermediate prevalences were observed. Thus, the estimation of overweight subjects was underestimated by 5% and 9% in men and women, respectively; for obesity, this under-estimation was 16% and 33%, for men and women respectively.
Information on personal advice offered to subjects considered as obese at interview were obtained (Table  3) . A total of 86% and 82% of obese men and women, respectively, were offered personal advice. However,
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only 39% of obese men and 36% of obese women said they had received written material. Advice from a nutritionist was offered only in 18% of obese men and 20% of obese women.
Discussion
In this European study, 23% of men and 33% of women were obese at least 6 months after hospitalization for coronary heart disease. When we considered the initial hospitalization records, we noticed an over-estimation of height, decreasing body mass index estimations and thus an under-estimation of obesity by 16% in men and 33% in women. Finally, the help provided by physicians professionally to support obese patients in their weight loss remains limited: only one to five obese patients were offered advice from a nutritionist.
Whatever the European country, at least 6 months after a coronary heart disease, 80% of men and 75% of women are overweight and almost one to four are obese. This observation of such prevalences in coronary heart disease patients has already been reported in specific populations [10, 11] . The EUROASPIRE study tends to demonstrate that these prevalences, estimated with standardized protocols, may apply to most European coronary heart disease patients. The lowest overweight prevalence detected for women in Hungary, was 60%, while the highest was 87% in Spanish women. Concerning obesity, the lowest prevalence was 16% in Dutch men and the highest 45% in Finnish women. Although more variable, overweight affected at least three out of five coronary heart disease patients in Europe. These data underline the impact of overweight and obesity on heart attack morbidity and mortality [12] . Weight loss in obese patients has an independent effect on coronary heart disease risk reduction, but also improves lipid plasma distribution, decreases blood pressure levels and increases glucose tolerance [13] . This impact may be more effective in obese subjects with coronary heart disease. In the recent recommendations published by the European task forces [7] , coronary heart disease patients are given top priority for action. The EUROASPIRE survey allowed us to estimate the extensive potential for secondary prevention offered by obesity and overweight reduction in Europe.
One major point about obesity compared to other modifiable risk factors, such as hypertension or dyslipidaemia, is that a patients' appearance may immediately indicate whether they are affected by the risk factor or not. However, empirical estimations are not so obvious. Indeed, as in patients with coronary disease, underestimation of obesity is also observed in the general population [14] where only 55% of obese women and 60% of obese men, according to measured values, were correctly classified as such.
This observation strongly argues for a systematic measurement of height and weight in coronary heart disease patients as a standard and major outcome of any in-or outpatient examination. This suggestion is reinforced by what we observed in height and weight values noted in medical files used to recruit coronary heart disease patients in EUROASPIRE survey. In all countries, height was over-estimated, mainly due to self-reported values in medical files. This increase in height induced a bias in body mass index estimation and in overweight and obesity prevalences. The systematic measurement of height and weight at admission will correct this bias. From an epidemiological point of view [15] , this well known bias has a little impact on correlation and quantitative measurement of body mass index used as a covariate. Conversely, in clinical practice, where thresholds are used, the misclassification will have a serious effect on the potential decision of management.
This prerequisite of secondary prevention is reinforced by the low frequency of help provided to obese patients. For obese subjects at interview, more than 80% had received advice, but less than 40% received written material and less than 20% met a nutritionist. If we consider the recommendations for secondary prevention, to make healthy food choices as one way to help weight control, the following recommendations are given as optimal dietary goals: reduction of total fat intake to 30% and of cholesterol intake to less than 300 mg . day 1 ; reduction of saturated fats, an increase in the intake of fresh fruit, cereals and vegetables, a reduction in total calorie intake and in salt and alcohol 
Centre
At admission (1) At admission (2) At interview (3) % of the difference* 
BMI calculated using height and weight as found in record.
BMI calculated using weight as found in record and height as measured at interview.
BMI calculated using weight and height measured at interview. *% of underestimation was calculated between prevalence at admission (1) and at admission (2) . Other abbreviations as in Table 1 . Table 2b Prevalence of obesity (body mass index d30 kg . m 2 ) in percentages by centre and sex
At admission (1) At admission (2) At interview (3) % of the difference* (1) BMI calculated using height and weight as found in record. (2) BMI calculated using weight as found in record and height as measured at interview.
BMI calculated using weight and height measured at interview. *% of underestimation was calculated between prevalence at admission (1) and at admission (2) . Other abbreviations as in Table 1 .
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use; and an increase in exercise. To offer oral advice, in the course of an in-or outpatient examination, will probably be of little impact. At least some of these recommendations have to be written down. Moreover, the role of a nutritionist, in order to transform this recommendation into applicable daily meals, is compulsory.
As reported from the EUROASPIRE data on overweight and obesity, there is a considerable opportunity for improving secondary prevention of coronary heart disease in Europe, by taking into account and managing this risk factor. Modification of lifestyle is difficult [11] , but health promotion trials in high cardiovascular risk individuals has been shown to be effective. Several experiments have been conducted in general practice, more amenable to long-term health promotion of coronary heart disease patients. In Ireland, despite no significant effect on objective cardiovascular risk factors, personal health education of patients with angina tended to increase exercise and improve dietary habits [16] . A randomized trial of the effect of promotion of lifestyle aspects of secondary prevention of coronary heart disease patients in general practice improved patients' health and reduced hospital admission [17] .
In conclusion, although regularly recommended, overweight and obesity are major modifiable risk factors to fight against. However, four conditions are needed to achieve this major public health goal: firstly, to systematically measure weight and height of coronary heart disease patients; secondly, to derive from these measures the body mass index; thirdly, to make a decision about management of patients with a body mass index d25 kg . m 2 and more urgently with a body mass index d30 kg . m 2 ; fourthly, to give written material to the patients and to agree upon a scheduled prevention programme with a nutritionist. For this lifestyle advice to be effective, a long-term follow-up of the patients is needed, with continuous management from hospital to the general physician's office. EUROASPIRE Study Group is grateful to all the hospitals in which the study was carried out. Their administrative staff, physicians, nurses and other personnel helped us in many ways and we very much appreciate this. We are also grateful to the patients who participated in the survey.
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